| Nazwa produktu: |
siarczan morfiny |
| Synonimy |
Siarczan morfiny (bezwodny); Embeda; Astramorf PF; Duramorf PF; Kapanol; MST-1 jest kontynuowany; siarczan morfiny; Morfina, pó?siarczan; NIH 0001; NIH 10753; NSC 11441; Oramorf SR; Skenan; UNII-DY70C97N30; siarczan l-morfiny; Morfinan-3,6-alfa-diol, 7,8-didehydro-4, 5-alfa-epoksy-17-metylo-siarczan; morfinan-3,6-diol, 7,8-didehydro-4,5-epoksydo-17-metylo-(5alfa,6alfa)-, siarczan (2:1) (sól); Morfinan-3,6alfa-diol, 7,8-didehydro-4,5alfa-epoksy-17-metylo-siarczan (2:1) (sól); siarczan bis[(6beta,9alfa,13alfa,14alfa)-17-metylo-7,8-didehydro-4,5-epoksymorfinan-17-ium-3,6-diol]; siarczan (5alfa,6alfa)-17-metylo-7,8-didehydro-4,5-epoksymorfinano-3,6-diolu (sól) |
| Angielska nazwa |
morphine sulphate; Morphine sulfate (anhydrous); Embeda; Astramorph PF; Duramorph PF; Kapanol; MST-1 Continus; Morphine sulphate; Morphine, hemisulfate; NIH 0001; NIH 10753; NSC 11441; Oramorph SR; Skenan; UNII-DY70C97N30; l-Morphine sulfate; Morphinan-3,6-alpha-diol, 7,8-didehydro-4, 5-alpha-epoxy-17-methyl-, sulfate; Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5alpha,6alpha)-, sulfate (2:1) (salt); Morphinan-3,6alpha-diol, 7,8-didehydro-4,5alpha-epoxy-17-methyl-, sulfate (2:1) (salt); bis[(6beta,9alpha,13alpha,14alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-17-ium-3,6-diol] sulfate; (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol sulfate (salt) |
| MF |
C17H21NO7S |
| Masie cz?steczkowej |
383.4161 |
| InChI |
InChI=1/C17H19NO3.H2O4S/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18;1-5(2,3)4/h2-5,10-11,13,16,19-20H,6-8H2,1H3;(H2,1,2,3,4)/t10-,11+,13-,16-,17-;/m0./s1 |
| Nr CAS |
64-31-3 |
| EINECS |
200-582-8 |
| Struktury molekularnej |
|
| Temperatura wrzenia |
476.2°C at 760 mmHg |
| Temperatura zap?onu |
241.8°C |
| Ci?nienie pary |
7.06E-10mmHg at 25°C |
| Symbole zagro?enia |
|
| Kody ryzyka |
|
| Bezpieczeństwo opis |
|
|
PL
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PT
RU
SA
TR
